AtraZeneca reports that it is migrating its legacy systems to the cloud through RISE with SAP, in a project that seeks to simplify its operations, harmonize data and lay the foundation to accelerate the adoption of artificial intelligence.

The biopharmaceutical company has begun the migration of its business systems to SAP Cloud ERP Private through RISE with SAP. The project extends a technological relationship of more than 20 years between both organizations and represents one of the largest implementations of SAP solutions in the health sciences sector.

The initiative is part of the Axial Business Transformation program, with which AstraZeneca aims to modernize and simplify its technological infrastructure. To do this, it is moving its legacy SAP ECC environments to SAP Cloud ERP Private, with the aim of standardizing processes, harmonizing data and improving the connection between different business areas.

This change will allow the biopharmaceutical company to have a more agile and resilient digital platform, capable of facilitating better-informed decision making, accelerating its operations and generating value for both the company and its stakeholders.

AstraZeneca specializes in the discovery, development and marketing of prescription medicines. Its activity is mainly concentrated in areas such as oncology, rare diseases, cardiovascular, renal and metabolic pathologies, as well as respiratory and immunological diseases.

“SAP has been a fundamental part of how we manage our operations for more than two decades,” said Chris Taylor, Chief Information Officer (CIO) at AstraZeneca. «This new stage of our collaboration goes far beyond modernizing technology. Through Axial, we are simplifying the way AstraZeneca operates and creating the foundation to move faster and better realize the value of AI. “This is important because the sooner we can turn information into action, the sooner we can create value for our company and for patients.”

Data and artificial intelligence

The evolution of SAP systems will also allow AstraZeneca to advance the incorporation of new enterprise artificial intelligence capabilities. In this area, the company is exploring different proposals from the SAP ecosystem, including the Industry AI portfolio, the Joule assistant and different use cases based on AI agents applied to the areas of finance, supply chain and manufacturing.

These technologies can help increase productivity, improve data quality and governance, and streamline decision processes. To achieve this, having an integrated and reliable information infrastructure is one of the main requirements.

SAP Business Data Cloud also plays a relevant role in this strategy, helping AstraZeneca to consolidate and purify its different data sets to build a reliable source of information. This base will facilitate the progressive incorporation of new artificial intelligence applications and will allow for better use of the information generated by the organization.

Sustainability criteria for business processes

Adding to this initiative is SAP Green Ledger, a solution that allows you to connect sustainability data with the company’s financial and operational information throughout its value chain. In this way, AstraZeneca will be able to incorporate sustainability criteria into its business processes and take them into account in decision-making.

“In the healthcare and life sciences sectors, companies are rethinking how technology can help them manage complexity and generate more value,” said Thomas Saueressig, Chief Customer Officer and member of the Board of Management of SAP SE.

«AstraZeneca’s Axial Transformation program demonstrates how cloud, data and AI can create a stronger foundation for innovation at scale. By helping to simplify operations, streamline decision-making and leverage trusted information, we can support AstraZeneca in its mission to push the boundaries of science and deliver life-changing medicines to patients around the world,” he concluded.